Drive for generics sees Korea increasingly attractive to international pharma31 Jul 2019
Korean companies are opening more facilities overseas and using CPhI Korea to look for new international partners.
Already home to more than 40 pharmaceutical multinationals, Korea is on course to become a global biotech and pharmaceutical hub by 2025, driven by the surge of international partnerships, biosimilars, an expansion in the export of finished formulations and a robust generics market.
In fact, South Korean President Moon Jae-in stated in May 2019 that the Government will help foster ‘the biotechnology and pharmaceutical sectors as the country's new economic growth drive’.
Emphasizing the shift in the country’s global reputation, provisional data from the CPhI Annual Report 2019 shows that Korea improved its scores across ‘API quality’, ‘growth potential’ and ‘innovation’, with ‘overall competitiveness’ rising by 9% in the last year.
The new findings are announced in the lead-up to CPhI Korea – co-organised by Informa Markets and the Korea Pharmaceutical Traders Association (KPTA) – which will open its sixth edition at the Seoul COEX Convention and Exhibition Centre from 21-23 August 2019.
“The show is widely seen as a barometer of industry trends within the region and this year we expect to see an increase in international bio buyers looking for access to services, equipment and bio-solutions as well as domestic partners. In total, over 5000 attendees from more than 50 countries and more than 190 exhibitors will attend” commented Laura Murina, Brand Manager at Informa.
Korean pharmaceutical exports have become attractive due to competitive pricing in the generics market and, as a result, Korean companies are opening more facilities overseas and using CPhI Korea to look for new international partners. In fact, the Korea Trade-Investment Promotion Agency (KOTRA) is facilitating exhibitors to meet with overseas buyers selected by the Global Bio Pharma Plaza (GBPP) at the event.
Emphasizing the international nature of Korea’s growth in exports, the CPhI Korea Conference, an integral part of the event, will include sessions from the Thai FDA, the Japanese PMDA, the China Chamber of Commerce for Imports and Exports of Medicines and Health Products (CCCMHPIE), as well as the European Directorate for the Quality of Medicines. The agenda will include detailed analysis of international regulations, GMP, QbD, and comparative strategies for global market entry.
Murina, continued: “South Korea’s expanding generics market and changing regulations are driving more international companies towards local partnerships. One of the great added benefits of this event’s size and dynamics is that it allows attendees to have more in-depth and targeted meetings. The high quality of meetings means that they deliver a very high rate of partnership outcomes.”
Finally, to help international companies looking to enter the country, CPhI Korea is working with the Korea Pharmaceutical Traders Association (KPTA) to promote a Meet the Expert Programme, which is specifically designed to help international companies understand the complexities of the South Korean market.
CPhI Worldwide to transform into Festival of Pharma digital experience
30 Jun 2020
The 10-day event will feature an interactive digital marketplace for sourcing products and services, enhanced matchmaking for connecting with new and existing partners, and world-renowned speakers.Read more
AI to deliver next evolution of drug manufacturing and supply chain efficiency
9 Jun 2020
Webinar will help manufacturers to harness the advantages of using real-time analytics to enhance performance and reduce waste.Read more
Pharmapack expert recommends holistic approach to sustainability
18 May 2020
Although the industry might be 30% along its sustainability journey, greater interoperability is needed from materials to devices.Read more
Rescheduled CPhI South East Asia moved to November
4 May 2020
Second postponement will provide improved confidence and market conditions for exhibitors and visitors.Read more
New technologies for solid dosage forms from Syntegon
28 Apr 2020
Syntegon's new coater series can handle tablets with highly potent active ingredients.Read more
CPhI & P-MEC China moves to December to enable international attendance
21 Apr 2020
Date alteration taken at the request of exhibitors to ensure the international character of China’s largest pharma exhibition.Read more
2020 CPhI Pharma Awards are open for entries
21 Apr 2020
Submit your entry before 1 July 2020!Read more
The future of liquid pharmaceutical processing on show ... virtually!
20 Apr 2020
Syntegon to showcase flexible solutions for small and microbatches, new developments for liquid filling and assembly, as well as AI-enhanced product safety.Read more
CPhI announces new pharma events calendar for 2020
17 Mar 2020
Organizers secure three new dates for events in Japan, South East Asia and North America in response to COVID-19.Read more
CPhI Japan 2020 Postponed
27 Feb 2020
Rescheduling will ensure all stakeholders can take part in a successful exhibition and conference.Read more
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation